Guru Ownership Trend
Guru Analysis for Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. (CGEM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $19.65 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $5.46 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Paul Tudor Jones reduced exposure by 65.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Cullinan Therapeutics, Inc. (CGEM)
Major holders include Renaissance Technologies (RenTech) ($6.54 M), Steven Cohen ($3.73 M), Cliff Asness ($2.91 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.28 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $5.46 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CGEM. The total reported sell value was $195,201.37.
Yes, 1 managers opened new positions in CGEM, and 2 increased their existing holdings. The total reported buy value was $5.65 M.